Lung cancer is the first fatal cancer in China

The daily meeting of October 20 to meet the "international lung cancer Concern Month", by the Chinese Cancer Association of Clinical Oncology Professional Committee (CSCO) sponsored by the Shanghai Roche Pharmaceutical Co., Ltd., co-organised by the "heart-hand-linked--csco dream line" Media will be held in Xiamen.　　The meeting launched the "heart-hand-linked--csco" activities, and invited two lung cancer fighting for many years "fight against lung cancer fighters" came to the scene to share experience.　　It is reported that "heart hand linked--csco" Activities will be launched through the survival of patients survey, online "fight against lung cancer fighters" selection, invite patients to participate in "Expo Tour", free clinics and other activities, to encourage more patients with lung cancer brave face disease, chasing dreams, live out wonderful! Advanced lung cancer patients from the scene Lin Shihua said: "Late lung cancer, although terrible, but the desire to give up their dreams and survival is more terrible." Although dreams of walking, running, and family outings are tiny, they mean a lot to us. For these dreams can be realized, I fight with lung cancer to this day!　　”。 Lung cancer is one of the world's most common cancers, with 1.2 million new cases each year, of which about 80% of non-small-cell lung cancer. Lung cancer is China's first deadly cancer, with 600,000 patients dying each year from lung cancer. According to the director of Lung Cancer Professional Committee of China Anti-Cancer Association, Professor Wu Yilong, deputy dean of Guangdong Provincial People's Hospital, said: "The early onset of lung cancer is secretive, most non-small cell patients are found to be locally advanced or metastasis, missed surgery." The emergence of targeted drugs has given hope for survival to patients with failed chemotherapy. "Compared to traditional chemotherapy," rather than "kill 1000, can not let go of a" treatment, targeted therapy directly on the tumor cells, by inhibiting the tumor cell epidermal growth factor receptor (EGFR) tyrosine kinase, cut off the tumor cells to transport nutrients in the pipeline, so as to kill the tumor cell function,　　Avoid the traditional chemotherapy caused by white blood cell decline, nausea, vomiting and other strong side effects, and only one oral daily, significantly improve the quality of life of patients. Lung Cancer Clinical Medicine Center Director, China Anti-Cancer Association Lung Cancer Professional Committee deputy chairman Yu Sun said: "In the past patients found lung cancer, often choose chemotherapy regimen." When chemotherapy is effective and cancer cells are temporarily under control, the traditional treatment mentality is "wait and watch" (Waiting and observing) mode, patients can only wait for disease development, accept the second line, third line chemotherapy, so it is very likely to miss the best time to effectively delay the progress of the disease. The 2009 European Society for Clinical Oncology Annual conference published the latest data on Saturn research. The results show that Tarceva is used to maintain treatment after platinum-type first-line chemotherapy, which can significantly reduce the risk of tumor progression, prolong the disease progression time and tolerate good tolerance.